Peginterferon -2b Injection for the Treatment of Pediatric RSV Bronchiolitis
Status:
RECRUITING
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, positive-controlled, non-inferiority clinical study, planning to enroll 90 children with bronchiolitis caused by respiratory syncytial virus infection, to evaluate the safety and efficacy of inhaled Peginterferon -2b injection compared to recombinant human interferon 2b in the treatment of pediatric respiratory syncytial virus bronchiolitis.